London, Jan 21 (ANI): A new drug for multiple sclerosis could soon be available for the first time within two years, say researchers at Queen Mary, University of London.
As per a major trial of the oral drug Cladribine, the pill significantly reduces relapse and deterioration of the disease, and goes a long way to eliminating the unpleasant side effects associated with existing therapies.
The results of the trial are published in the New England Journal of Medicine.
Cladribine promises to be the first ever treatment in tablet form for MS, and only needs be taken for between 8 to 10 days a year.
Multiple sclerosis is a disabling neurological condition. It results from the body's own immune system damaging the central nervous system. (ANI)